Cott (TSE:PRM) Rating Increased to Strong-Buy at BMO Capital Markets

BMO Capital Markets upgraded shares of Cott (TSE:PRM) to a strong-buy rating in a research note released on Monday morning,Zacks.com reports.

Several other equities research analysts also recently commented on the company. William Blair raised Cott to a “strong-buy” rating in a report on Thursday, October 24th. Raymond James cut shares of Cott from a “moderate buy” rating to a “hold” rating in a report on Wednesday, October 2nd.

Cott Stock Up 0.3 %

Shares of PRM stock opened at C$13.30 on Monday. The company’s 50-day moving average price is C$13.26. Cott has a fifty-two week low of C$12.95 and a fifty-two week high of C$14.97.

Cott Dividend Announcement

The firm also recently announced a None dividend, which was paid on Thursday, November 21st. Stockholders of record on Tuesday, November 5th were issued a $1.109 dividend. The ex-dividend date was Tuesday, November 5th.

Cott Company Profile

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.